The Company Profile of Qinyang Pharmaceutical Factory
 
  Sign In Join Help
 
Qinyang Pharmaceutical Factory

 
  Recommended Results
  Company Description
Qinyang Pharmaceutical Factory, originated in the august of 1992.The annual production of inositol has been up to 800 tons. In July 2002, Qinyang Pharmaceutical Factory was authorized by State of drug production with the code number approved by SFDA H41022891. After acquiring the State’s permit of drug production, the enterprise further standardized the producing procedure and adopted the technological transformation. In 2003, supervised by the State Food and Drug Administration (SFDA), we passed the authentication and gained GMP certificate of State drug production enterprise in March of 2004. The factory was inspected by SFDA in 2009 and regained GMP certificate, which made our factory one of the two manufacturers in China owning GMP certificate for Pharmaceutical Grade inositol.
  ProductsKeyword
inositol, Inositol NF12, inositol FCC

  Contact information
Company :  Qinyang Pharmaceutical Factory
Email:  Contact us
URL:  ********
Phone:  *********
Fax :  *********
Country :  China
Address :  *********

  Showroom
Commerce Member:
Please log in your ID and password, we will later fill in relating info.
 
ID: Password: Remember my ID on this computer
Complete this form below to send out your enquiries.
All enquiries will be automatically sent to the company you want to develop.
Subject
Content (Don't input Company Name, E-Mail, Phone Number, Fax Number, and URL)
   

 


Company Profile:
* Company Name
*E-mail
*Country
*Contact Person
URL
*Phone
- -
Fax
- -
*Postal code
*City
*Street Address
*Business Nature
Distributor   Exporter Importer Manufacturer
Whole Sale Retailer  Reseller Retrofitter User
Others, please specify:
*Security Code
Enter the security code.


Site Map l   Privacy Policy l Company Profile l Corporate Proposal l Contact Us l Help l Advertise With Us l  World Trade Link
Copyright©2024, G.T. Internet Information Co., Ltd. All Rights Reserved.     .